1 | BECLOMETHASONE DIPROPIONATE & CLOTRIMAZOLE CREAM | Composition : | | |
| | Beclomethasone Dipropionate IP | 0.025%w/w | |
| | Clotrimazole IP | 1.0%w/w | |
| | Cream base | q.s. | |
2 | BECLOMETHASONE DIPROPIONATE, CLOTRIMAZOLE & | Composition | | |
| NEOMYCIN SULPHATE CREAM | Beclomethasone Dipropionate IP | 0.025%w/w | |
| | Clotrimazole IP | 1.0 %w/w | |
| | Neomycin Sulphate IP | 0.5%w/w | |
| | Cream base | q.s | |
3 | BENZOIC & SALISYLIC ACIDS OINTMENT IP | Composition: | | |
| | Salisylic Acid IP | 3.0%w/w | |
| | Benzoic Acid IP | 6.0%w/w | |
| | Ointment base | q.s | |
4 | BENZYL BENZOATE APPLICATION IP | Composition: | | |
| | Benzyl Benzoate IP | 25%w/w | |
| | Oil in water emulsified base | q.s | |
5 | BETAMETHASONE VALERATE CREAM IP | Composition : | | |
| | Betamethasone Valerate IP | | |
| | Equ.to Betamethsone | 0.1 %w/w | |
| | Cream base | q.s | |
6 | BETAMETHASONE DIPROPIONATE CREAM IP | Composition : | | |
| | Betamethasone Dipropionate IP | | |
| | Equ. To Betamethasone | 0.1%w/w | |
| | Cream base | q.s | |
7 | BETAMETHASONE DIPROPIONATE OINTMENT IP | Composition : | | |
| | Betamethasone Dipropionate IP | | |
| | Equ.to Betamethsone | 0.05%w/w | |
| | Ointment base | q.s | |
8 | CALAMINE LOTION IP | Composition: | | |
| | Calamine | 15%w/w | |
| | Zinc Oxide | 5.0%w/w | |
| | Bentonite | 3.0.%w/w | |
| | Sodium Citrate | 0.5%w/w | |
| | Liquefied Phenol | 0.5%w/v | |
| | Glycerin | 5.0%w/v | |
| | Water soluble base | q.s | |
9 | CLINDAMYCIN PHOSPHATE GEL | Composition: | | |
| | Clindamycin Phosphate IP | | |
| | Equ. To Clindamycin | 1.0 %w/w | |
| | Gel base | q.s | |
10 | CLINDAMYCIN VAGINAL CREAM | Composition: | | |
| | Clindamycin Phosphate IP | | |
| | Equ To Clindamycin | 2%w/w | |
| | Cream Base | q.s | |
11 | CHOLINE SALICYLATE SOLUTION & LIGNOCAINE HYDROCHLORIDE GEL | Composition : | | |
| | Choline Salicylate Solution BP | | |
| | Equ. To Cholin Salicylate | 9.0 %w/w | |
| | Lignaocaine Hydrochloride IP | 2.0%w/w | |
| | Gel base | q.s | |
12 | CHLORAMPHENICOL CREAM USP | Composision : | | |
| | Chloramphenicol IP | 1.0 %w/w | |
| | Cream base | q.s | |
13 | CLOBETASOL PROPIONATE & GENTAMYCIN | Composition : | | |
| CREAM | Clobetasole Propionate IP | 0.05%w/w | |
| | Gentamycin Sulphate IP | 0.1%w/w | |
| | Cream base | q.s | |
14 | CLOBETASOL PROPIONATE CREAM IP | Composition | | |
| | Clobetasol Propionate IP | 0.05%w/w | |
| | Cream base | q.s | |
15 | CLOBETASOL PROPIONATE OINTMENT IP | Composition: | | |
| | Clobetasol Propionate IP | 0.05% w/w | |
| | Ointment base | q.s | |
16 | CLOBETASOL PROPIONATE, NEOMYCIN SULPHATE, | Composition : | | |
| MICONAZOLE NITRATE CREAM | Clobetasol Propionate IP | 0.05%w/w | |
| | Neomycin Sulphate IP | | |
| | Equ. To Neomycin | 0.5%w/w | |
| | Miconazole Nitrate IP | 2.0 %w/w | |
| | Cream base | q.s. | |
17 | CLOBETASOL PROPIONATE, GENTAMICIN SULPHATE & | Composition : | | |
| MICONAZOLE NITRATE CREAM | Clobetasol Propionate USP | 0.05%w/w | |
| | Gentamicin Sulphate IP | | |
| | Equ. To Gentamicin | 0.2%w/w | |
| | Miconazole Nitrate IP | 2.0 %w/w | |
| | Cream base | q.s | |
18 | CLOTRIMAZOLE ORAL MOUTH PAINT | Composition : | | |
| | Clotrimazole IP | 1.0 % w/w | |
| | Glycerine & Propyelene glycol base | q.s | |
19 | CLOTRIMAZOLE CREAM IP | Composition : | | |
| | Clotrimazole IP | 1%w/w | |
| | Cream base | q.s | |
20 | CLOTRIMAZOLE DUSTING POWDER | Composition | | |
| | Clotrimazole IP | 1 %w/w | |
| | Talcum & Starch Base | qs. | |
21 | CLOTRIMAZOLE VAGINAL CREAM | Composition: | | |
| | Clotrimazole IP | 1 %w/w | |
| | Cream base | q.s | |
22 | CLOTRIMAZOLE VAGINAL CREAM | Composition: | | |
| | Clotrimazole IP | 10 %w/w | |
| | Cream base | q.s | |
23 | CLOTRIMAZOLE CREAM BP | Composition | | |
| | Clotrimazole BP | 1%w/w | |
| | Cream base q.s | | |
24 | CLOTRIMAZOLE CREAM IP | Composition : | | |
| | Clotrimazole IP | 2%w/w | |
| | Cream base | q.s | |
25 | DICLOFENAC DIETHYLAMINE, METHYL SALICYLATE,MENTHOL & | Composition : | | |
| & OLIUM LINI GEL | Diclofenac Diethylamine BP | 1.16 % w/w | |
| | Equ. To Diclofenac Sodium | 1.0 % w/w | |
| | Methyl Salicylate IP | 10.0%w/w | |
| | menthol IP | 5 %w/w | |
| | Olium Lini BP | 3.0 %w/w | |
| | Gel base | q.s | |
26 | DICLOFENAC DIETHYLAMINE, METHYL | Composition : | | |
| SALICYLATE,LINSEED OIL WITH | Diclofenac Diethylamine BP | 1.16 % w/w | |
| MENTHOL GEL | Equ. To Diclofenac Sodium | 1.0 % w/w | |
| | Methyl Salicylate IP | 10.0%w/w | |
| | Menthol IP | 0.5 %w/w | |
| | Linseed Oil BP | 3.0 %w/w | |
| | Gel base | q.s | |
27 | DICLOFENAC DIETHYLAMINE, METHYL | Composition : | | |
| SALICYLATE,LINSEED OIL, | Diclofenac Diethylamine BP | 1.16 % w/w | |
| MENTHOL & CAPSAICIN GEL | Equ. To Diclofenac Sodium | 1.0 % w/w | |
| | Methyl Salicylate IP | 10.0%w/w | |
| | Menthol IP | 5 %w/w | |
| | Linseed Oil BP | 3.0 %w/w | |
| | Capsaicin BP | 0.01%w/w | |
| | Gel base | q.s | |
28 | DICLOFENAC GEL BP | Composition | | |
| | Diclofenac Diethylamine BP | 1.16 %w/w | |
| | Equ. To Diclofenac Sodium | 1.0 %w/w | |
| | Gel base q.s | | |
29 | DINOPROSTONE VEGINAL GEL IP | Each gm containes: | | |
| | Dinoprotone IP | 2 mg | |
| | Gel base | | |
30 | ESTRIOL VAGINAL CREAM IP | Each gm containes: | | |
| | Estriol IP | 0.1%w/w | |
| | Cream base | | |
31 | FLUOCINOLONE WITH NEOMYCIN CREAM | Composition | | |
| | Fluocinolone Acetonide IP | 0.025 %w/w | |
| | Neomycin Sulphate IP | | |
| | Equ To Neomycin | 0.5%w/w | |
| | Cream base | q.s | |
32 | FLUCONAZOLE & ZINC PYRITHIONE LOTION | Composition : | | |
| | Fluconazole IP | 2 %w/v | |
| | Zinc Pyrithione (ZPTO) | 1%w/v | |
| | Lotion base | q.s | |
| | Colour : Erythrosine | | |
33 | FLUOCINOLONE ACETONIDE, NEOMYCIN SULPHATE & | Composition | | |
| MICONAZOLE NITRATE CREAM | Fluocinolone Acetonide IP | 0.01 %w/w | |
| | Neomycin Sulphate IP | 0.5 %w/w | |
| | Miconazole Nitrate IP | 2.0 %w/w | |
| | Cream base q.s | | |
34 | FLUOCINOLONE CREAM IP | Composition | | |
| | Fluocinolone Acetonide IP | 0.05 %w/w | |
| | Cream base q.s | | |
35 | FLUTICASONE PROPIONATE & FUSIDIC ACID CREAM | Composition : | | |
| | Fluticasone Propionate IP | 0.05 %w/w | |
| | Fusidic Acid IP | 2% w/w | |
| | Cream base | q.s | |
36 | FUSIDIC ACID OINTMENT | Composition: | | |
| | Fusidic Acid IP | 2 %w/w | |
| | Ointment base | q.s | |
37 | GAMMA BENZINE HEXA CHLORIDE SOLUTION | Composition: | | |
| | Gamma Benzine Hexa Chloride | 1% w/v | |
| | Water soluble base | q.s | |
38 | GENTIAN VIOLET TOPICAL SOLUTION USP | Composition: | | |
| | Gentian Violet USP | 0.5%w/v | |
| | Water soluble base | q.s | |
39 | GENTAMICIN SULPHATE CREAM IP | Composition : | | |
| | Gentamicin Sulphate IP | | |
| | Equ. To Gentamicin | 0.1 %w/w | |
| | Cream base | q.s | |
40 | HALOBETASOL PROPIONATE & SALICYLIC ACID OINTMENT | Composition : | | |
| | Halobetasol Propionate USP | 0.05 %w/w | |
| | Salicylic Acid IP | 3 % w/w | |
| | Ointment base | q.s | |
41 | HALOBETASOL PROPIONATE & FUSIDIC ACID OINTMENT | Composition : | | |
| | Halobetasol Propionate USP | 0.05 %w/w | |
| | Fusidic Acid IP | 2 % w/w | |
| | Ointment base | q.s | |
42 | HYDROQUINONE, TRETINOIN & MOMETASONE | Composition : | | |
| FUROATE CREAM | Hydroquinone USP | 2.0%w/w | |
| | Tretinoin BP | 0.25 %w/w | |
| | Mometasone Furoate IP | 0.1 % w/w | |
| | Cream base | q.s | |
43 | KETOCONAZOLE CREAM | Composition : | | |
| | Ketoconazole IP | 2%w/w | |
| | Cream base | q.s | |
44 | LULICONAZOLE LOTION | Composition : | | |
| | Luliconazole | 1%w/v | |
| | Lotion base | q.s | |
45 | METRONIDAZOLE VAGINAL GEL | Composition: | | |
| | Metronidazole IP | 0.75 %w/w | |
| | Gel base | q.s | |
46 | MICONAZOLE NITRATE CREAM IP | Composition: | | |
| | Miconazole Nitrate IP | 2.0 %w/w | |
| | Cream base | q.s | |
47 | MINOXIDIL SCALP APPLICATION BP | Composition : | | |
| | Minoxidil IP | 12.5 % w/v | |
| | Isopropyl Alcohol IP ( As vehicle) | q.s | |
48 | MINOXIDIL SCALP APPLICATION BP | Composition : | | |
| | Minoxidil IP | 5 % w/v | |
| | Isopropyl Alcohol IP ( As vehicle) | q.s | |
49 | MINOXIDIL SCALP APPLICATION BP | Composition : | | |
| | Minoxidil IP | 10 % w/v | |
| | Isopropyl Alcohol IP ( As vehicle) | q.s | |
50 | MINOXIDIL & AMINEXIL SCALP APPLICATION | Composition : | | |
| | Minoxidil IP | 2% w/v | |
| | Aminexil | 1.5% w/v | |
| | Absolute Alcohol IP | 63% v/v | |
| | Adhesive base | q.s | |
51 | MINOXIDIL & AMINEXIL SCALP APPLICATION | Composition : | | |
| | Minoxidil IP | 5% w/v | |
| | Aminexil | 1.5% w/v | |
| | Absolute Alcohol IP | 63% v/v | |
| | Adhesive base | q.s | |
52 | MOMETASONE FUROATE & SALICYLIC ACID LOTION | Composition : | | |
| | Mometasone Furoate USP | 0.1 %w/v | |
| | Salicylic Acid IP | 3.5% w/v | |
| | Lotion base | q.s | |
53 | MOMETASONE FUROATE & FUSIDIC ACID CREAM | Composition : | | |
| | Mometasone Furoate USP | 0.1 %w/w | |
| | Fusidic Acid IP | 2% w/w | |
| | Cream base | q.s | |
54 | MUPIROCIN OINTMENT IP | Composition : | | |
| | Mupirocin IP | 2%w/w | |
| | Onitment base | q.s | |
55 | NITROFURAZONE OINTMENT | Composition : | | |
| | Nitrofurazone IP | 2%w/w | |
| | Onitment base | q.s | |
56 | PERMETHRIN LOTION | Composition: | | |
| | Permethrin | 1%w/v | |
| | base | q.s | |
57 | POVIDONE IODINE SOLUTION IP | Composition: | | |
| | Povidone Iodine IP | 7.5.0 %w/v | |
| | (avilable iodine 0.75 %w/v) | | |
| | Purified water IP | q.s | |
58 | POVIDONE- IODINE OINTMENT USP | Composition: | | |
| | Povidone Iodine IP | 5.0 %w/w | |
| | (avilable Iodine 0.5 %w/w) | | |
| | Water soluble ointment base | q.s | |
59 | POVIDONE IODINE SOLUTION IP | Composition: | | |
| | Povidone Iodine IP | 5.0 %w/v | |
| | (avilable iodine 0.5 %w/v) | | |
| | Purified water IP | q.s | |
60 | POVIDONE-IODINE DROP | Composition: | | |
| | Povidone-Iodine IP | 0.06 %w/w | |
| | (Avilable Iodine) | 0.006 %w/w | |
| | Water soluble base | q.s | |
61 | SALICYLIC ACID WITH | Composition: | | |
| CLOBETASOL PROPIONATE CREAM | Salicylic acid IP | 3.5 %w/w | |
| | Clobetasol Propionate IP | 0.05% w/w | |
| | Cream base | q.s | |
62 | SALICYLIC ACID & BENZOIC ACID LOTION | Composition : | | |
| | Salicylic Acid IP | 7.31%w/v | IP |
| | Benzoic Acid IP | 2.44%w/v | |
| | Alcohol base | q.s | |
63 | SALICYLIC ACID WITH BETAMETHASONE CREAM | Composition: | | |
| | Betamethsone Dipropionate IP | 0.064 % w/w | |
| | Salicylic acid IP | 3.0 %w/w | |
| | Cream base | q.s | |
64 | SALISYLIC ACID OINTMENT | Composition: | | |
| | Salisylic Acid IP | 3.0%w/w | |
| | Ointment base | q.s | |
65 | SERTACONAZOLE NITRATE CREAM | Composition : | | |
| | Sertaconazole Nitrate BP | 2%w/w | |
| | Cream base | q.s | |
66 | TACROLIMUS CREAM | Composition : | | |
| | Tacrolims IP | | |
| | Equ. To Anhydous Tacrolimus | 0.03%w/w | |
67 | TERBINAFINE HYDROCHLORIDE CREAM IP | Composition : | | |
| | Terbinafine Hydrochloride IP | 1.0 %w/w | |
| | Cream base | q.s | |
68 | WHITFIELD'S OINTMENT | Composition: | | |
| | Salisylic Acid IP | 3.0%w/w | |
| | Benzoic Acid IP | 6.0%w/w | |
| | Ointment base | q.s | |
69 | XYLOCAINE JELLY | Composition : | | |
| | Xylocaine IP | 2%w/v | |
| | | | |